Partner with IDEOM
IDEOM brings patients, clinicians, researchers, industry, payers, patient advocacy groups and the FDA together to develop patient-centered outcome measures in dermatology. Our community includes more than 1,300 stakeholders in 46 countries across 11 disease states. We invite industry partners to have a seat at the table.
Our sponsorship packages are valid for one year and support IDEOM’s in-person Annual Meeting. All industry corporate sponsors are invited to attend the Annual Meeting and actively participate.
Why Sponsor IDEOM?
-
Multidisciplinary Perspectives
Clinicians, researchers, industry, government, and patients work closely together on each disease state.
-
Full Participation
Industry scientists fully participate and vote in the workgroups they join, working alongside clinicians and patients research partners.
-
Work with Knowledgeable Patient Research Partners
IDEOM trains our patient partners in outcome measure development, so their insight is informed, specific, and actionable. The patient voice is key to IDEOM’s success.
-
Opportunities Across Your Full Pipeline
Participate across the workgroups that match your therapeutic areas.
Partner in Advancing Research and Treatment
Join our ongoing pursuit to enhance research and treatment for those with dermatologic conditions.
Sponsorship Inquiries
Sponsorship opportunities are available by request.
Please contact Amanda Pacia, Association Manager, at amanda@dermoutcomes.org, or email info@dermoutcomes.org to learn about IDEOM’s industry opportunities.
Whether you've been a long-standing supporter or are considering joining us for the first time, know that your support will make a significant impact. We look forward to hearing from you!
About IDEOM
International Dermatology Outcome Measures (IDEOM) is working to establish patient-centered measurements to enhance the research and treatment of those with dermatological diseases. Our priority is to create meaningful endpoints for use in clinical trials that can carry over into clinical practice, taking into account the needs of patients, providers, researchers, payers, and regulators.
IDEOM recognizes the inconsistency and unmet needs in current tools and measurements, and together with relevant stakeholders, including clinicians, methodologists, patients, pharmaceutical colleagues, insurers, regulatory agencies, and policy regulators, our goal is to address these gaps in clinical endpoints.